Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies

Journal of Autoimmunity

Volumn 17, Issue 1, 2001, Pages 63-69

  Herkel, Johannes ^a   Mimran, Avishai ^b   Erez, Neta ^b   Kam, Naaman ^b   Lohse, Ansgar W ^a   Märker Hermann, Elisabeth ^a   Rotter, Varda ^b   Cohen, Irun R ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Anti DNA; Apoptosis; Molecular mimicry; p53; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; IDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY; PROTEIN P53; SYNTHETIC PEPTIDE;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; MOLECULAR MIMICRY; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN INDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0035422831     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2001.0518     Document Type: Article

References (29)

1. Systemic lupus erythematosus
2. The immunologic properties of DNA
3. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus
4. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
5. Systemic exposure to irradiated apoptotic cells induces autoantibody production
6. Inhibition of Caspase-3-mediated Poly(ADP-ribose) Polymerase (PARP) apoptotic cleavage by human PARP antibodies and effect on cells undergoing apoptosis
7. Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic diseases
8. p53: Puzzle and paradigm
9. Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the carboxy-terminal domain of p53 that recognizes damaged DNA
10. The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation
11. Immunologically distinct p53 molecules generated by alternative splicing
12. A DNA binding domain is contained in the C-terminus of wild type p53 protein
13. The DNA binding activity of wild type p53 is modulated by blocking its various antigenic epitopes
14. Monoclonal antibody analysis of p53 expression in normal and transformed cells
15. Definition of a consensus binding site for p53
16. Regulation of the specific DNA binding function of p53
17. Small peptides activate the latent sequence-specific DNA binding function of p53
18. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: Generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis
19. Immunity to mutant p53 and tumor rejection induced by idiotypic immunization
20. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors
21. Overexpression of p53 protein during pancreatitis
22. The humoral response to the tumor-suppressor gene product p53 in human cancer: Implications for diagnosis and therapy
23. Serum p53 antibodies in patients with chronic inflammatory bowel disease
24. High levels of p53 protein in UV-irradiated normal human skin
25. p53 autoantibodies in patients with autoimmune diseases: A quantitative approach
26. Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: Distribution on primary structure and exposure on protein surface
27. Role of a major autoepitope in forming the DNA binding site of the p70 (Ku) antigen
28. Cell injury mediated by autoantibodies to intracellular antigens